SE8502910L - Aryl-10-dihydroxi-1,8-antroner och deras salter, forfarande for framstellning derav och anvendning derav inom human- eller veterinermedicinen samt inom kosmetiken - Google Patents

Aryl-10-dihydroxi-1,8-antroner och deras salter, forfarande for framstellning derav och anvendning derav inom human- eller veterinermedicinen samt inom kosmetiken

Info

Publication number
SE8502910L
SE8502910L SE8502910A SE8502910A SE8502910L SE 8502910 L SE8502910 L SE 8502910L SE 8502910 A SE8502910 A SE 8502910A SE 8502910 A SE8502910 A SE 8502910A SE 8502910 L SE8502910 L SE 8502910L
Authority
SE
Sweden
Prior art keywords
aryl
image
antrons
dihydroxy
cosmetics
Prior art date
Application number
SE8502910A
Other languages
English (en)
Other versions
SE459807B (sv
SE8502910D0 (sv
Inventor
B Shroot
G Lang
J Maignan
S Restle
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of SE8502910D0 publication Critical patent/SE8502910D0/sv
Publication of SE8502910L publication Critical patent/SE8502910L/sv
Publication of SE459807B publication Critical patent/SE459807B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE8502910A 1984-06-13 1985-06-12 10-aryl-1, 8-dihydroxi-antroner, foerfarande foer framstaellning daerav och farmaceutiska eller kosmetiska kompositioner SE459807B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8409203A FR2565966B1 (fr) 1984-06-13 1984-06-13 Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique

Publications (3)

Publication Number Publication Date
SE8502910D0 SE8502910D0 (sv) 1985-06-12
SE8502910L true SE8502910L (sv) 1985-12-14
SE459807B SE459807B (sv) 1989-08-07

Family

ID=9304944

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502910A SE459807B (sv) 1984-06-13 1985-06-12 10-aryl-1, 8-dihydroxi-antroner, foerfarande foer framstaellning daerav och farmaceutiska eller kosmetiska kompositioner

Country Status (11)

Country Link
JP (1) JPS6140238A (sv)
BE (1) BE902642A (sv)
CA (1) CA1253859A (sv)
CH (1) CH664557A5 (sv)
DE (1) DE3521074A1 (sv)
DK (1) DK265185A (sv)
FR (1) FR2565966B1 (sv)
GB (1) GB2160864B (sv)
IT (1) IT1190365B (sv)
NL (1) NL8501699A (sv)
SE (1) SE459807B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843097A (en) * 1984-06-13 1989-06-27 Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics
DE4231636A1 (de) * 1992-09-22 1994-03-24 Beiersdorf Ag Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung
US5426197A (en) * 1993-07-19 1995-06-20 Teva Pharmaceutical Industries, Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31289A (en) * 1968-01-08 1974-01-14 Ciba Geigy Ag Pharmaceutical preparation containing a dermatologically active difluorinated corticoid and dithranol
DE2154608A1 (de) * 1970-11-12 1972-06-29 Ciba-Geigy Ag, Basel (Schweiz) Neues Diacetat, pharmazeutische Präparate und Herstellungsverfahren
DE3002089A1 (de) * 1980-01-22 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue, substituierte 1,8-dihydroxy-9-(10h)-anthracenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2495934A1 (fr) * 1980-12-15 1982-06-18 Cird Composition pour le traitement du psoriasis a base d'une dihydroxy-1,8 anthrone-9 substituee en position 10

Also Published As

Publication number Publication date
FR2565966A1 (fr) 1985-12-20
SE459807B (sv) 1989-08-07
IT1190365B (it) 1988-02-16
JPS6140238A (ja) 1986-02-26
SE8502910D0 (sv) 1985-06-12
CA1253859A (fr) 1989-05-09
CH664557A5 (fr) 1988-03-15
IT8521130A0 (it) 1985-06-12
BE902642A (fr) 1985-12-12
GB2160864B (en) 1987-12-31
DE3521074A1 (de) 1985-12-19
NL8501699A (nl) 1986-01-02
GB2160864A (en) 1986-01-02
DK265185A (da) 1985-12-14
FR2565966B1 (fr) 1986-08-29
GB8514973D0 (en) 1985-07-17
DK265185D0 (da) 1985-06-12

Similar Documents

Publication Publication Date Title
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
ZA875168B (en) Substituted amino-5,6,7,8-tetrahydronaphthyloxyacetic acids,processes for their preparation and their use as medicaments
SE8700458D0 (sv) Fergkomposition for keratinfibrer och i synnerhet for menniskohar baserad pa halogenerade nitroaniliner, forfarande for fergning med anvendning av fergkompositionen och nya anvenda halogenerade 2-nitroaniliner
FR2581993B1 (fr) Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
IT1177803B (it) Procedimento per il trattamento di elementi strutturali poliglolici per uso chirurgico per modificarne le proprieta' fisiche in-vivo
FI894061A0 (sv) Förfarande för framställning av , -disubstituerade N-cykloalkylalkylbensylaminer, vilka är användbara som läkemedel, och deras syntesmellanprodukter
DE3670081D1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
SE8502525L (sv) 1,3-oxazolidin-2-on-derivat och forfaranden for framstellning derav
FR2549049B1 (fr) Nouvelles amidines, leur procede de preparation et leur application therapeutique
DK178883A (da) 2-(2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, syreadditionssalte deraf, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater med indhold deraf
ATE61040T1 (de) Substituierte 2-nitrometaphenylendiamine, verfahren zu ihrer herstellung und ihre verwendung fuer die faerbung von keratinischen fasern, insbesondere von menschlichen haaren.
SE8704979L (sv) Nya furanuronsyraderivat, forfarande for deras framstellning och deras anvendning
SE8502910L (sv) Aryl-10-dihydroxi-1,8-antroner och deras salter, forfarande for framstellning derav och anvendning derav inom human- eller veterinermedicinen samt inom kosmetiken
ATE74913T1 (de) 2,4,6-triaminopyrimidin n-3-oxid-harnstoffderivate, deren herstellung und deren kosmetische und dermopharmazeutische verwendung.
ES527353A0 (es) Procedimiento de preparacion de nuevos derivados de la nitrosourea
ES542393A0 (es) "4-(nitrofenil)-tetrahidropiridinas,procedimiento para su obtencion y su empleo como medicamento"
EP0114750A3 (en) Beta-lactam antibacterial agents
PT82407B (pt) Processo para a preparacao de novos derivados do triazole
DK149199C (da) Analogifremgangsmaade til fremstilling af hexahydro-1,4-oxazepiner eller salte deraf dannet med fysiologisk acceptable syrer
BR8805537A (pt) Composicoes herbicidas ou reguladoras do crescimento de plantas,processo para obtencao de compostos,utilizacao de tais compostos,processo para combate de crescimento indesejado de plantas ou para regulagem de crescimento de plantas,e processo para obtencao de isocianatos de n-sultamsulfonila intermediarios para os ditos compostos
DK280883D0 (da) Organophosphat-derivater, fremgangsmade til fremstilling deraf samt deres anvendelse som midler til bekaempelse af skadelige organismer
DE69200840D1 (de) Harnstoff- und Thioharnstoffderivate, Herstellung und therapeutische Verwendung.
DK600585D0 (da) 2,3-diamino-2,3-didesoxyhexosederivater, fremgangsmaade til fremstilling deraf samt anvendelse deraf
DE3162380D1 (en) N-sulfenyl ureas, preparation, fungicidal compositions and use thereof
ATE96144T1 (de) 2-aminoacetamid derivate.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8502910-6

Effective date: 19940110

Format of ref document f/p: F